Physiologically-based pharmacokinetic modelling of the 2-monthly regimen of long-acting injectable rilpivirine administered in pregnancy

被引：0
|
作者：
Atoyebi, Shakir [1 ]
Siccardi, Marco [1 ]
Waitt, Catriona [1 ]
机构：
[1] Univ Liverpool, Liverpool, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 2023年 / 180卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P0643
引用
收藏
页码：338 / 340
页数：3
相关论文
共 50 条
  • [21] Evaluating Islatravir Administered Via Microneedle Array Patch for Long-Acting HIV Pre-exposure Prophylaxis Using Physiologically Based Pharmacokinetic Modelling (vol 47, pg 855, 2022)
    Kinvig, Hannah
    Cottura, Nicolas
    Lloyd, Andrew
    Frivold, Collrane
    Mistilis, Jessica
    Jarrahian, Courtney
    Siccardi, Marco
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2023, 48 (01) : 119 - 119
  • [22] The Switch From Paliperidone Long-Acting Injectable 1-to 3-Monthly Clinical Pharmacokinetic Evaluation in Patients With Schizophrenia (Preliminary Data)
    Mauri, Massimo Carlo
    Franco, Gemma
    Minutillo, Alessandro
    Paletta, Silvia
    Di Pace, Chiara
    Reggiori, Alessandra
    Baldelli, Sara
    Cattaneo, Dario
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2022, 42 (01) : 23 - 30
  • [23] Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia
    Uchida, Hiroyuki
    Mamo, David C.
    Kapur, Shitij
    Labelle, Alain
    Shammi, Chekkera
    Mannaert, Erik J. L.
    Mann, Steve W.
    Remington, Gary
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (08) : 1281 - 1286
  • [24] How Population-Based Pharmacokinetic Modeling (PopPK) is Used in the Development and Approval of Long-Acting Injectable Medications Using the 2-Month Dosing Regimen of Aripiprazole Lauroxil as an Example
    Preskorn, Sheldon
    Weiden, Peter
    Hard, Marjie
    Wehr, Angela
    von Moltke, Lisa
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S239 - S239
  • [25] Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder
    Shenkoya, Babajide
    Gopalakrishnan, Mathangi
    Eke, Ahizechukwu C.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (11): : 1939 - 1952
  • [26] Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
    Jongen, Vita W.
    Wit, Ferdinand W. N. M.
    Boyd, Anders
    van Eeden, Arne
    Brouwer, Annemarie E.
    Soetekouw, Robert
    El Moussaoui, Rachida
    Stalenhoef, Janneke
    Sigaloff, Kim C. E.
    Mudrikova, Tatiana
    Gisolf, Jet
    Burger, David
    Wensing, Annemarie M. J.
    van der Valk, Marc
    LANCET HIV, 2025, 12 (01): : e40 - e50
  • [27] Impact of a pharmacist-administered long-acting injectable antipsychotic service in a supermarket-based community pharmacy on medication adherence
    Lin, Christine
    Strauss, Rebecca
    Hong, Jenny
    Hamper, Jeffrey G.
    Hoy, Emma Sew
    Lazar, Ann A.
    Kroon, Lisa
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2019, 2 (04): : 343 - 348
  • [28] CABOTEGRAVIR AND RILPIVIRINE LONG-ACTING ANTIRETROVIRAL THERAPY ADMINISTERED EVERY 2-MONTHS IS COST EFFECTIVE FOR THE TREATMENT OF HIV-1 IN SPAIN
    Moreno Guillen, S.
    Rivero, A.
    Ventayol, P.
    Falco, V.
    Torralba, M.
    Schroeder, M.
    Neches, V.
    Vallejo-Aparicio, L. A.
    Mackenzie, I.
    Turner, M.
    Harrison, C.
    VALUE IN HEALTH, 2022, 25 (12) : S122 - S122
  • [29] Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study
    Gaur, Aditya H.
    Capparelli, Edmund, V
    Calabrese, Katherine
    Baltrusaitis, Kristin
    Marzinke, Mark A.
    McCoig, Cynthia
    Van Solingen-Ristea, Rodica M.
    Mathiba, Sisinyana Ruth
    Adeyeye, Adeola
    Moye, John H.
    Heckman, Barbara
    Lowenthal, Elizabeth D.
    Ward, Shawn
    Milligan, Ryan
    Samson, Pearl
    Best, Brookie M.
    Harrington, Conn M.
    Ford, Susan L.
    Huang, Jenny
    Crauwels, Herta
    Vandermeulen, Kati
    Agwu, Allison L.
    Smith-Anderson, Christiana
    Camacho-Gonzalez, Andres
    Ounchanum, Pradthana
    Kneebone, Jared L.
    Townley, Ellen
    Moore, Carolyn Bolton
    LANCET HIV, 2024, 11 (04): : e211 - e221
  • [30] Cabotegravir and Rilpivirine Long-Acting Antiretroviral Therapy Administered Every 2 Months is Cost-Effective for the Treatment of HIV-1 in Spain
    Moreno, Santiago
    Rivero, Antonio
    Ventayol, Pere
    Falco, Vicenc
    Torralba, Miguel
    Schroeder, Melanie
    Neches, Victoria
    Vallejo-Aparicio, Laura Amanda
    Mackenzie, Isaac
    Turner, Matthew
    Harrison, Cale
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (08) : 2039 - 2055
12345